Bal Pharma Limited

NSEI:BALPHARMA Stock Report

Market Cap: ₹2.1b

Bal Pharma Management

Management criteria checks 3/4

Bal Pharma's CEO is Shailesh Siroya, appointed in Aug 2019, has a tenure of 5.25 years. total yearly compensation is ₹10.20M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 19.27% of the company’s shares, worth ₹399.11M. The average tenure of the management team and the board of directors is 4.2 years and 4.5 years respectively.

Key information

Shailesh Siroya

Chief executive officer

₹10.2m

Total compensation

CEO salary percentage100.0%
CEO tenure5.3yrs
CEO ownership19.3%
Management average tenure4.2yrs
Board average tenure4.5yrs

Recent management updates

Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Sep 19
Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 18
Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Recent updates

Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Sep 19
Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Bal Pharma (NSE:BALPHARMA) Is Increasing Its Dividend To ₹1.20

Aug 31
Bal Pharma (NSE:BALPHARMA) Is Increasing Its Dividend To ₹1.20

Bal Pharma Limited's (NSE:BALPHARMA) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Aug 27
Bal Pharma Limited's (NSE:BALPHARMA) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Bal Pharma (NSE:BALPHARMA) Is Paying Out A Larger Dividend Than Last Year

Aug 15
Bal Pharma (NSE:BALPHARMA) Is Paying Out A Larger Dividend Than Last Year

Insufficient Growth At Bal Pharma Limited (NSE:BALPHARMA) Hampers Share Price

May 30
Insufficient Growth At Bal Pharma Limited (NSE:BALPHARMA) Hampers Share Price

Does Bal Pharma (NSE:BALPHARMA) Have A Healthy Balance Sheet?

Mar 14
Does Bal Pharma (NSE:BALPHARMA) Have A Healthy Balance Sheet?

Bal Pharma Limited's (NSE:BALPHARMA) 26% Share Price Surge Not Quite Adding Up

Feb 01
Bal Pharma Limited's (NSE:BALPHARMA) 26% Share Price Surge Not Quite Adding Up

Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 18
Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Bal Pharma (NSE:BALPHARMA) Is Due To Pay A Dividend Of ₹1.00

Aug 28
Bal Pharma (NSE:BALPHARMA) Is Due To Pay A Dividend Of ₹1.00

Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Aug 14
Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Aug 17
Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Bal Pharma (NSE:BALPHARMA) Has Announced A Dividend Of ₹1.00

Jul 31
Bal Pharma (NSE:BALPHARMA) Has Announced A Dividend Of ₹1.00

Is Bal Pharma (NSE:BALPHARMA) Using Too Much Debt?

Mar 08
Is Bal Pharma (NSE:BALPHARMA) Using Too Much Debt?

Bal Pharma (NSE:BALPHARMA) Use Of Debt Could Be Considered Risky

Nov 23
Bal Pharma (NSE:BALPHARMA) Use Of Debt Could Be Considered Risky

Does Bal Pharma Limited (NSE:BALPHARMA) Have A Place In Your Dividend Stock Portfolio?

Aug 10
Does Bal Pharma Limited (NSE:BALPHARMA) Have A Place In Your Dividend Stock Portfolio?

Should You Buy Bal Pharma Limited (NSE:BALPHARMA) For Its 2.3% Dividend?

Aug 10
Should You Buy Bal Pharma Limited (NSE:BALPHARMA) For Its 2.3% Dividend?

CEO Compensation Analysis

How has Shailesh Siroya's remuneration changed compared to Bal Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹77m

Jun 30 2024n/an/a

₹76m

Mar 31 2024₹10m₹10m

₹74m

Dec 31 2023n/an/a

₹35m

Sep 30 2023n/an/a

₹32m

Jun 30 2023n/an/a

₹24m

Mar 31 2023₹12m₹12m

₹26m

Dec 31 2022n/an/a

₹29m

Jun 30 2022n/an/a

₹43m

Mar 31 2022₹10m₹10m

₹56m

Dec 31 2021n/an/a

₹72m

Jun 30 2021n/an/a

₹59m

Mar 31 2021₹10m₹10m

₹47m

Dec 31 2020n/an/a

-₹34m

Sep 30 2020n/an/a

-₹73m

Jun 30 2020n/an/a

-₹95m

Mar 31 2020₹10m₹10m

-₹122m

Dec 31 2019n/an/a

-₹52m

Sep 30 2019n/an/a

-₹15m

Jun 30 2019n/an/a

-₹21m

Mar 31 2019₹8m₹8m

₹38m

Dec 31 2018n/an/a

₹29m

Mar 31 2018₹8m₹8m

₹28m

Compensation vs Market: Shailesh's total compensation ($USD120.82K) is above average for companies of similar size in the Indian market ($USD42.64K).

Compensation vs Earnings: Shailesh's compensation has been consistent with company performance over the past year.

CEO

Shailesh Siroya (58 yo)

5.3yrs

Tenure

₹10,200,000

Compensation

Mr. Shailesh Dheerajmal Siroya serves as the Managing Director of BAL Pharma Limited. Mr. Siroya served as the Managing Director of BAL Pharma Limited since August 1, 1994. With rich experience, Mr. Siroya...

Leadership Team

NamePositionTenureCompensationOwnership
Shailesh Siroya
MD & Executive Director5.3yrs₹10.20m19.27%
₹ 399.1m
Daddanala Bharath Bhushan
Chief Financial Officerno data₹2.60mno data
Abdul Basith
Company Secretary & Compliance Officer1.3yrs₹540.00kno data
Himesh Virupakshaya
Whole Time Director4.2yrs₹3.32m0.17%
₹ 3.5m
Ravindra Kothari
Deputy General Manager of Internal Auditno datano datano data
D. Bhat
Assistant Vice President of Sales & Marketingno datano datano data
Archana Mitra
Vice President of International Marketing & HRno data₹534.34kno data
Kotian Damodar
Whole Time Directorno data₹1.87mno data

4.2yrs

Average Tenure

59.5yo

Average Age

Experienced Management: BALPHARMA's management team is considered experienced (4.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Shailesh Siroya
MD & Executive Director27.2yrs₹10.20m19.27%
₹ 399.1m
Himesh Virupakshaya
Whole Time Director5.2yrs₹3.32m0.17%
₹ 3.5m
Kotian Damodar
Whole Time Director2.5yrs₹1.87mno data
Nicola Neeladrie
Independent Non-Executive Director4.5yrs₹52.00kno data
H. Venkatesh
Non-Executive Additional Independent Director4.5yrs₹61.00kno data
Jatish Sheth
Non-Executive Independent Director3.9yrs₹61.00kno data

4.5yrs

Average Tenure

63yo

Average Age

Experienced Board: BALPHARMA's board of directors are considered experienced (4.5 years average tenure).